Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-10-26 | Future report Set alerts | |
Q2 2022 | 2022-07-26 | 0.58 | 0.58 |
Q1 2022 | 2022-04-26 | 0.80 | 0.80 |
Q4 2021 | 2022-02-03 | 0.43 | 0.43 |
Q3 2021 | 2021-10-28 | 0.66 | 0.66 |
Q2 2021 | 2021-07-22 | 0.88 | 0.88 |
Q1 2021 | 2021-04-22 | 0.68 | 0.68 |
Q4 2020 | 2021-02-04 | 0.24 | 0.24 |
Q3 2020 | 2020-10-29 | 0.00 | 0.00 |
Q2 2020 | 2020-07-23 | -0.44 | -0.44 |
2016-06-06 | Reiterated Rating | Morgan Stanley | Buy | |
2016-04-25 | Reiterated Rating | B. Riley | Buy | $42.00 |
2016-04-20 | Reiterated Rating | B. Riley | Buy | $40.00 |
2016-04-07 | Downgrade | OTR Global | Positive | |
2016-04-07 | Initiated Coverage | Macquarie | Outperform | $45.00 |
2016-04-04 | Boost Price Target | Dundee Securities | C$1.60 to C$1.75 | |
2016-02-14 | Reiterated Rating | B. Riley | Buy | $40.00 |
2016-02-11 | Boost Price Target | Susquehanna | Neutral | $30.00 to $31.00 |
2016-02-11 | Boost Price Target | Cowen and Company | $33.00 to $34.00 | |
2016-02-11 | Lower Price Target | BB&T Corp. | Buy | $50.00 to $40.00 |
2016-02-09 | Reiterated Rating | B. Riley | Buy | $40.00 |
2016-01-22 | Reiterated Rating | Sterne Agee CRT | Buy | $54.00 |
2016-01-22 | Downgrade | Susquehanna | Positive to Neutral | $28.02 to $30.00 |
2016-01-19 | Lower Price Target | Canaccord Genuity | Spec Buy | C$2.75 to C$2.25 |
2016-01-04 | Initiated Coverage | Cowen and Company | Market Perform | $33.00 |
2015-12-03 | Lower Price Target | National Bank Financial | Outperform | C$2.50 to C$2.25 |
2015-12-02 | Reiterated Rating | Sterne Agee CRT | Buy | $54.00 |
2015-12-01 | Reiterated Rating | Beacon Securities | Buy | |
2015-11-27 | Lower Price Target | TD Securities | Speculative Buy | C$3.00 to C$2.50 |
2015-11-16 | Lower Price Target | Susquehanna | Positive | $45.00 to $30.00 |
2015-11-04 | Reiterated Rating | Sterne Agee CRT | Buy | |
2015-10-31 | Reiterated Rating | B. Riley | Buy | $40.00 |
2015-10-26 | Reiterated Rating | B. Riley | Buy | $40.00 |
2015-10-24 | Reiterated Rating | Sterne Agee CRT | Buy | $62.00 to $54.00 |
2015-10-23 | Lower Price Target | Susquehanna | Positive | $55.00 to $45.00 |
2015-10-23 | Lower Price Target | Citigroup Inc. | $53.00 to $44.00 | |
2015-10-23 | Lower Price Target | Monness Crespi & Hardt | Buy | $53.00 to $41.00 |
2015-10-23 | Downgrade | Buckingham Research | Buy to Neutral | $55.00 to $30.00 |
2015-10-21 | Reiterated Rating | B. Riley | Buy | $54.00 |
2015-10-20 | Lower Price Target | Buckingham Research | $55.00 | |
2015-10-16 | Initiated Coverage | BB&T Corp. | Buy | $150.00 |
2015-10-13 | Initiated Coverage | Argus | Buy | $51.67 |
2015-09-06 | Reiterated Rating | Sterne Agee CRT | Buy | $61.67 |
2015-08-07 | Boost Price Target | Sterne Agee CRT | Buy | $53.33 to $61.67 |
2015-07-30 | Boost Price Target | Monness Crespi & Hardt | Buy | $41.67 to $53.33 |
2015-07-30 | Reiterated Rating | Citigroup Inc. | Buy | $53.33 |
2015-07-30 | Boost Price Target | Sterne Agee CRT | Buy | $42.33 to $53.33 |
2015-07-29 | Set Price Target | B. Riley | Buy | $45.00 to $53.33 |
2015-07-22 | Reiterated Rating | B. Riley | Buy | $45.00 |
2015-07-21 | Boost Price Target | Citigroup Inc. | Buy | $42.33 to $47.33 |
2015-07-17 | Reiterated Rating | Morgan Stanley | Buy | |
2015-07-17 | Boost Price Target | B. Riley | Buy | $39.33 to $45.00 |
2015-06-26 | Reiterated Rating | Wunderlich | Buy | $45.67 |
2015-06-14 | Reiterated Rating | Sterne Agee CRT | Buy | $42.33 |
2015-06-09 | Boost Price Target | Susquehanna | Positive | $39.00 to $42.33 |
2015-06-08 | Boost Price Target | Monness Crespi & Hardt | Buy | $30.00 to $41.67 |
2015-06-02 | Reiterated Rating | B. Riley | Buy | $39.33 |
2015-05-29 | Boost Price Target | Wunderlich | Buy | $32.33 to $45.67 |
2015-05-26 | Reiterated Rating | B. Riley | Buy | $30.67 to $39.33 |
2015-05-19 | Boost Price Target | Susquehanna | Positive | $29.67 to $39.00 |
2015-05-08 | Boost Price Target | Sterne Agee CRT | Buy | $30.00 to $37.00 |
2015-05-07 | Boost Price Target | Citigroup Inc. | Buy | $31.00 to $35.33 |
2015-04-30 | Reiterated Rating | B. Riley | Buy | $30.67 |
2015-04-24 | Reiterated Rating | Sterne Agee CRT | Buy | $27.67 to $30.00 |
2015-04-23 | Boost Price Target | Citigroup Inc. | Buy | $27.33 to $31.00 |
2015-04-23 | Upgrade | Buckingham Research | Neutral to Buy | $20.67 to $31.33 |
2015-04-23 | Boost Price Target | Monness Crespi & Hardt | Buy | $24.67 to $30.00 |
2015-04-23 | Upgrade | B. Riley | Neutral to Buy | $30.67 |
2015-04-20 | Lower Price Target | Wunderlich | Buy | $34.00 to $32.33 |
2015-04-15 | Reiterated Rating | Sterne Agee CRT | Buy | $27.67 |
2015-04-15 | Boost Price Target | Susquehanna | Positive | $26.00 to $27.33 |
2015-04-01 | Reiterated Rating | Sidoti | Buy | |
2015-02-16 | Reiterated Rating | B. Riley | Neutral | $23.67 |
2015-02-12 | Boost Price Target | Citigroup Inc. | Buy | $22.67 to $27.33 |
2015-02-12 | Upgrade | Buckingham Research | Underperform to Neutral | |
2015-02-12 | Boost Price Target | Monness Crespi & Hardt | Buy | $21.00 to $24.67 |
2015-02-12 | Boost Price Target | Wunderlich | Buy | $23.33 to $34.00 |
2015-02-09 | Set Price Target | Sterne Agee CRT | Buy | $23.33 |
2015-02-08 | Downgrade | B. Riley | Buy to Neutral | $22.00 |
2015-01-22 | Reiterated Rating | Sterne Agee CRT | Buy | $23.33 |
2014-10-30 | Initiated Coverage | Wunderlich | Overweight | $24.33 |
2014-10-30 | Initiated Coverage | Morgan Stanley | Overweight | $24.33 |
2014-10-23 | Reiterated | B. Riley & Co. | Buy | $58 to $66 |
2014-10-23 | Reiterated Rating | Citigroup Inc. | Buy | $22.00 to $22.67 |
2014-10-23 | Reiterated Rating | Wunderlich | Positive to Buy | $23.33 |
2014-10-23 | Boost Price Target | B. Riley | Buy | $19.33 to $22.00 |
2014-10-07 | Initiated Coverage | Monness Crespi & Hardt | Buy | $21.00 |
2014-09-04 | Initiated Coverage | Wunderlich | Buy | $23.33 |
2014-08-25 | Boost Price Target | Sterne Agee CRT | $20.00 to $23.33 | |
2014-08-20 | Boost Price Target | Citigroup Inc. | Buy | $20.00 to $22.00 |
2014-08-14 | Boost Price Target | Susquehanna | Positive | $20.00 to $21.67 |
2014-07-24 | Reiterated | B. Riley & Co. | Buy | $49 to $58 |
2014-07-24 | Upgrade | Sidoti | Neutral to Buy | |
2014-07-24 | Boost Price Target | B. Riley | $16.33 to $19.33 | |
2014-07-22 | Reiterated Rating | B. Riley | Buy | $16.33 to $19.33 |
2014-07-09 | Initiated Coverage | Sidoti | Neutral | |
2014-06-04 | Boost Price Target | Susquehanna | $16.00 to $18.33 | |
2014-05-30 | Boost Price Target | Citigroup Inc. | Buy | $16.33 to $17.33 |
2014-05-19 | Initiated Coverage | Citigroup Inc. | Buy | $16.33 |
2014-04-23 | Boost Price Target | Sterne Agee CRT | Buy | $14.33 to $16.67 |
2014-04-23 | Boost Price Target | Susquehanna | Positive | $13.33 to $16.00 |
2014-04-23 | Boost Price Target | B. Riley | Buy | $16.33 |
2014-04-10 | Initiated Coverage | Buckingham Research | Underperform | $9.67 |
2014-02-13 | Boost Price Target | Sterne Agee CRT | $14.33 | |
2014-01-21 | Downgrade | BB&T Corp. | Buy to Hold | $11.00 |
2013-12-05 | Set Price Target | Sterne Agee CRT | $12.00 to $13.33 | |
2013-10-30 | Initiated Coverage | Brean Capital | Buy | $13.00 |
2013-10-24 | Boost Price Target | BB&T Corp. | Buy | $10.00 to $11.00 |
2013-09-30 | Boost Price Target | Susquehanna | Positive | $32.00 to $36.00 |
2012-01-18 | Downgrade | BB&T Capital Mkts | Buy to Hold | |
2011-07-28 | Upgrade | BB&T Capital Mkts | Hold to Buy | |
2011-01-14 | Reiterated | Wedbush | Neutral | $23 to $21 |
2010-09-30 | Reiterated | Avondale | Mkt Outperform | $57 to $51 |
2010-09-10 | Downgrade | BB&T Capital Mkts | Buy to Hold | |
2010-07-23 | Reiterated | Avondale | Mkt Outperform | $47 to $51 |
2010-04-15 | Reiterated | Avondale | Mkt Outperform | $38 to $45 |
2009-10-06 | Reiterated | Sterne Agee | Buy | $20 to $21 |
2009-08-10 | Upgrade | Sterne Agee | Neutral to Buy | $20 |
2009-04-30 | Reiterated | Wedbush Morgan | Hold | $7 to $10 |
2009-02-19 | Reiterated | Wedbush Morgan | Hold | $6.50 to $7 |
2009-02-06 | Reiterated | CL King | Underperform | $10 to $7 |
2016-06-06 | Reiterated Rating | Morgan Stanley | Buy | |
2016-04-25 | Reiterated Rating | B. Riley | Buy | $42.00 |
2016-04-20 | Reiterated Rating | B. Riley | Buy | $40.00 |
2016-04-07 | Downgrade | OTR Global | Positive | |
2016-04-07 | Initiated Coverage | Macquarie | Outperform | $45.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In SKX 246 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
FMR LLC | 20.23M |
Vanguard Group, Inc | 12.32M |
BlackRock Inc. | 10.93M |
PZENA INVESTMENT MANAGEMENT LLC | 8.01M |
BlackRock Fund Advisors | 5.06M |
STATE STREET CORP | 4.78M |
Arrowpoint Asset Management, LLC | 4.70M |
Marshall Wace LLP | 4.09M |
BlackRock Institutional Trust Company, N.A. | 3.93M |
DIMENSIONAL FUND ADVISORS LP | 2.95M |
FIDUCIARY MANAGEMENT INC /WI/ | 2.48M |
Apex Capital Management | 2.44M |
Theleme Partners LLP | 2.27M |
Capital Research Global Investors | 2.25M |
MARSHALL WACE ASIA Ltd | 2.20M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
GREENBERG JEFFREY | 1.83% (745220) | SKX / |
GREENBERG ROBERT Chief Executive Officer | 1.64% (666583) | SKX / |
WEINBERG DAVID Chief Operating Officer | 0.99% (403004) | SKX / |
SISKIND RICHARD | 0.44% (180499) | SKX / |
NASON MARK A Executive Vice President | 0.12% (48751) | SKX / |
GREENBERG MICHAEL President | 0.10% (42389) | SKX / |
PACCIONE PHILLIP General Counsel & Secretary | 0.07% (30000) | SKX / |
Erlich Morton D | 0.06% (24500) | AVD / SKX / |
RAPPAPORT RICHARD | 0.05% (19000) | SKX / |
Walsh Thomas | 0.02% (10000) | SKX / |
KOSINSKI GEYER | 0.01% (3000) | SKX / |